Dibenzyline

Active Ingredient(s): Phenoxybenzamine
FDA Approved: * January 26, 1953
Pharm Company: * WELLSPRING PHARM
Category: Blood Pressure

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Dibenzyline Overview

Phenoxybenzamine (marketed under the trade name Dibenzyline) is a non-selective, irreversible alpha blocker. Contents 1 Uses 1.1 Investigational 2 Pharmacology 3 Stereoisomerism 4 See also 5 References Uses It is used in the treatment of hypertension, and specifically that caused by pheochromocytoma. It has a slower onset and a longer-lasting effect compared with other alpha blockers. It was also the first alpha blocker to be used for treatment of benign prostatic hyperplasia,&...

Read more Dibenzyline Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Phenoxybenzamine

Recent Dibenzyline Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Phenoxybenzamine
  • Capsule: 10mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Dibenzyline: (2 results)

Sorted by National Drug Code
  • 59212-001 Dibenzyline 10 mg Oral Capsule by Concordia Pharmaceuticals Inc.
  • 65197-001 Dibenzyline 10 mg Oral Capsule by Wellspring Pharmaceutical Corporation

Other drugs which contain Phenoxybenzamine or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA